BRPI0923599A2 - vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo - Google Patents

vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo

Info

Publication number: BRPI0923599A2
Authority: BR; Brazil
Prior art keywords: swine fever; classical swine; fever virus; animals; vaccine
Prior art date: 2008-12-23

Application number

BRPI0923599A

Other languages

English (en)

Inventor

Alexander Kortekaas Jeroen

Petronella Maria Vloet Rianka

Original Assignee

Intervet Int Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-23

Filing date

2009-12-23

Publication date

2019-09-24

2009-12-23 Application filed by Intervet Int Bv filed Critical Intervet Int Bv

2019-09-24 Publication of BRPI0923599A2 publication Critical patent/BRPI0923599A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
General Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)

BRPI0923599A 2008-12-23 2009-12-23 vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo BRPI0923599A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08172874A EP2202298A1 (en)	2008-12-23	2008-12-23	Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
PCT/NL2009/050801 WO2010074575A2 (en)	2008-12-23	2009-12-23	Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.

Publications (1)

Publication Number	Publication Date
BRPI0923599A2 true BRPI0923599A2 (pt)	2019-09-24

Family

ID=40601213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0923599A BRPI0923599A2 (pt)	2008-12-23	2009-12-23	vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo

Country Status (10)

Country	Link
US (1)	US8911744B2 (pt)
EP (2)	EP2202298A1 (pt)
JP (1)	JP5868182B2 (pt)
CN (1)	CN102317449B (pt)
BR (1)	BRPI0923599A2 (pt)
ES (1)	ES2546403T3 (pt)
HU (1)	HUE025711T2 (pt)
MX (1)	MX2011006846A (pt)
RU (1)	RU2501854C2 (pt)
WO (1)	WO2010074575A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2202298A1 (en) *	2008-12-23	2010-06-30	Stichting Dienst Landbouwkundig Onderzoek	Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
BR112012029145B8 (pt) *	2010-05-18	2022-03-08	Ceva Sante Animale	Vacina marcada para tratamento profilático da peste suína clássica, método de fabricação de uma vacina de uma cepa de vírus modificado, vivo e atenuado da peste suína clássica, e composição farmacêutica
CN103751773B (zh) *	2013-07-17	2016-05-18	哈尔滨维科生物技术开发公司	稳定表达猪瘟病毒e0-e1-e2蛋白的重组bhk细胞系及其在制备猪瘟疫苗与诊断试剂中的应用
ES2668459T3 (es) *	2013-12-19	2018-05-18	Intervet International B.V.	Prueba de diagnóstico mejorado para anticuerpos del VPPC
US9993544B2 (en)	2014-05-23	2018-06-12	Boehringer Ingelheim Vetmedica Gmbh	Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
CN105242044A (zh) *	2015-11-23	2016-01-13	新疆天康畜牧生物技术股份有限公司	猪瘟病毒e2蛋白定量的检测方法
CN107828745B (zh) *	2017-11-15	2021-01-05	中国兽医药品监察所	猪瘟兔化弱毒表位突变株及其应用
CN109781980A (zh) *	2019-01-30	2019-05-21	河南中泽生物工程有限公司	非洲猪瘟病毒快速检测卡及其应用
WO2020211801A1 (en) *	2019-04-18	2020-10-22	Boehringer Ingelheim Vetmedica (China) Co., Ltd.	Recombinant classical swine fever virus
GB201910794D0 (en) *	2019-07-29	2019-09-11	Pirbright Inst	Vaccine
CN113106071A (zh) *	2020-01-13	2021-07-13	中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心）	Hq06表位突变的猪瘟候选标记疫苗株及其应用
CN111718400B (zh) *	2020-06-15	2021-11-02	苏州世诺生物技术有限公司	猪瘟病毒重组抗原及其制备方法和应用
CN112625091B (zh) *	2020-12-25	2023-03-31	龙湖现代免疫实验室	一条结合猪瘟病毒Erns蛋白的多肽序列及应用
CN112707948B (zh) *	2020-12-25	2023-03-31	龙湖现代免疫实验室	一条结合猪瘟病毒e0蛋白的多肽序列及应用
EP4105225A1 (en) *	2021-06-18	2022-12-21	Institut de Recerca i Tecnologia Agroalimentàries	Peptide-based assay to differentiate animals infected with csfv from vaccinated animals
CN113512098B (zh) *	2021-07-15	2022-08-23	武汉大学	鉴别猪瘟病毒和牛病毒性腹泻病毒血清抗体间接elisa方法及其应用
CN114574503B (zh) *	2022-03-14	2024-03-29	成都史纪生物制药有限公司	一种猪瘟E2蛋白基因、猪伪狂犬病毒gD蛋白基因及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5149527A (en)	1990-09-18	1992-09-22	Oncotech, Inc.	Immunopotentiating protocol for chemotherapy-responsive tumors
CN101255433A (zh) *	1994-06-17	2008-09-03	动物保健研究所	瘟病毒株的核苷酸序列,由这些序列编码的多肽及其在诊断和预防瘟病毒感染中的应用
US6316007B1 (en)	1995-04-04	2001-11-13	Wound Healing Of Oklahoma	Combined physical and immunotherapy for cancer
EP0924298A1 (en)	1997-12-18	1999-06-23	Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO)	Protein expression in baculovirus vector expression systems
WO2000009159A1 (en)	1998-08-10	2000-02-24	Aquila Biopharmaceuticals, Inc.	Compositions of cpg and saponin adjuvants and methods thereof
EP1035205A1 (en) *	1999-03-08	2000-09-13	Stichting Dienst Landbouwkundig Onderzoek	Non-spreading pestivirus
DK1558276T3 (da) *	2002-11-08	2012-10-22	Univ Tulane	Flavivirus-fusionsinhibitorer
GB0323968D0 (en)	2003-10-13	2003-11-19	Glaxosmithkline Biolog Sa	Immunogenic compositions
US8846055B2 (en) *	2006-05-30	2014-09-30	The United States Of America, As Represented By The Secretary Of Agriculture	Virulence determinant within the E2 structural glycoprotein of classical swine fever virus
US8133495B2 (en) *	2007-05-22	2012-03-13	The United States Of America As Represented By The Secretary Of Agriculture	Live attenuated antigenically marked classical swine fever virus
EP2202298A1 (en) *	2008-12-23	2010-06-30	Stichting Dienst Landbouwkundig Onderzoek	Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV

2008
- 2008-12-23 EP EP08172874A patent/EP2202298A1/en not_active Withdrawn
2009
- 2009-12-23 WO PCT/NL2009/050801 patent/WO2010074575A2/en not_active Ceased
- 2009-12-23 EP EP09775363.6A patent/EP2382307B1/en active Active
- 2009-12-23 BR BRPI0923599A patent/BRPI0923599A2/pt not_active IP Right Cessation
- 2009-12-23 RU RU2011130829/10A patent/RU2501854C2/ru active
- 2009-12-23 ES ES09775363.6T patent/ES2546403T3/es active Active
- 2009-12-23 CN CN200980156450.7A patent/CN102317449B/zh active Active
- 2009-12-23 MX MX2011006846A patent/MX2011006846A/es active IP Right Grant
- 2009-12-23 US US13/141,182 patent/US8911744B2/en not_active Expired - Fee Related
- 2009-12-23 HU HUE09775363A patent/HUE025711T2/en unknown
- 2009-12-23 JP JP2011543453A patent/JP5868182B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2382307B1 (en)	2015-07-15
US8911744B2 (en)	2014-12-16
RU2011130829A (ru)	2013-01-27
EP2382307A2 (en)	2011-11-02
WO2010074575A3 (en)	2010-08-26
ES2546403T3 (es)	2015-09-23
EP2202298A1 (en)	2010-06-30
HUE025711T2 (en)	2016-04-28
US20110287044A1 (en)	2011-11-24
CN102317449A (zh)	2012-01-11
JP5868182B2 (ja)	2016-02-24
RU2501854C2 (ru)	2013-12-20
JP2012513212A (ja)	2012-06-14
WO2010074575A2 (en)	2010-07-01
CN102317449B (zh)	2014-07-23
MX2011006846A (es)	2011-09-09

Publication	Publication Date	Title
BRPI0923599A2 (pt)	2019-09-24	vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo
HUE043952T2 (hu)	2019-09-30	Módosított influenzavírus vakcinahatékonyság monitorozására és javítására
PL2281831T3 (pl)	2018-08-31	Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
EP2998315A3 (en)	2016-07-13	Newcastle disease virus vectored avian vaccines
MX341842B (es)	2016-09-02	Virus de la influenza capaces de infectar canidos y usos de los mismos.
CY1117673T1 (el)	2017-05-17	Ανασυνδυασμενα αντιγονα rsv
IL198466A (en)	2014-01-30	Use of dengue fever vaccines to produce a single-value vaccine and four-value vaccine to vaccinate against dengue fever virus and vaccine kits against dengue fever containing these vaccines
IL186710A (en)	2017-09-28	Influenza A virus is isolated from dogs, a drug and vaccine that include it and its use
EA201071365A1 (ru)	2011-08-30	Моноклональные антитела, имеющие гомоподтип кросс-нейтрализующих свойств против вируса гриппа а подтипа н1
BR112012023046A2 (pt)	2017-07-18	vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
DK1881845T3 (da)	2010-06-07	Nipah-virusvacciner
AR060565A1 (es)	2008-06-25	Vacuna para la gripe aviaria y metodos de uso
EP2897640A4 (en)	2016-09-07	HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIBODY PROTEIN AND VACCINE THEREWITH
CY1113540T1 (el)	2016-06-22	Εμβολια γριππης σκυλων
BRPI1011034A2 (pt)	2016-03-15	vacina de gripe universal baseada no vírus ancara vaccinia modificado (mva) recombinante
EA201001045A1 (ru)	2010-12-30	Модифицированный вирус гриппа
EP2437778A4 (en)	2013-07-24	RECOMBINANT WESTNILVIRUS SUBSIDIARY VACCINE FOR THE PROTECTION OF HUMAN LIFE
CO7461133A2 (es)	2015-11-30	Parvovirus 5a porcino, métodos de uso y vacuna
ATE490782T1 (de)	2010-12-15	Chimäre vakzine-antigene gegen das klassische schweinefieber-virus
CO7461135A2 (es)	2015-11-30	Parvovirus porcino 5b, métodos de uso y vacuna
AR047581A1 (es)	2006-01-25	Vacunas de calicivirus felino
BRPI0822947A2 (pt)	2015-06-23	Vacina recombinante, método para vacinação contra doenças de animais e método para identificação entre animais infectados e animais vacinados
EA201290319A1 (ru)	2012-12-28	Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания
BR112012004847A2 (pt)	2016-11-16	genoma bohv-4 mutante, vírus bohv-4 mutante, vacina, uso de um vírus bohv-4 mutante, célula, método para a produção de um genoma bohv-4 mutante ou um vírus bohv-4 mutante, e, kit de teste de diagnóstico para diferenciar animais infectados.
PH12014501688A1 (en)	2014-10-20	Influenza c virus and vaccine

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: dismissal - article 86 of industrial property law
2020-01-21	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.